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Background: We conducted a monthly epidemiological survey to determine the birth prevalence of Robin
sequence (RS) and the use of various therapeutic approaches for it.
Methods: Between August 2011 and July 2012, every pediatric department in Germany was asked to report new
admissions of infants with RS to the Surveillance Unit for Rare Pediatric Diseases in Germany. RS was defined as
retro- or micrognathia and at least one of the following: clinically evident upper airway obstruction including
recessions, snoring or hypoxemia; glossoptosis; feeding difficulties; failure to thrive; cleft palate or RS-associated
syndrome. Hospitals reporting a case were asked to return an anonymized questionnaire and discharge letter.
Results: Of 96 cases reported, we received detailed information on 91. Of these, 82 were included; seven were
duplicates and two erroneous reports. Given 662,712 live births in Germany in 2011, the birth prevalence was
12.4 per 100,000 live births. Therapeutic approaches applied included prone positioning in 50 infants, followed
by functional therapy in 47. Conventional feeding plates were used in 34 infants and the preepiglottic baton
plate (PEBP) in 19. Surgical therapy such as mandibular traction was applied in 2 infants, tracheotomy in 3.
Conclusion: Compared to other cohort studies on RS, surgical procedures were relatively rarely used as an initial
therapy for RS in Germany. This may be due to differences in phenotype or an underrecognition of upper airway
obstruction in these infants.
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In 1911, Shukowsky was the first to identify a small
mandible as responsible for dyspnea and cyanosis in
newborns [1]. In 1923, the French stomatologist Pierre
Robin described infants with a hypoplastic mandible and
glossoptosis resulting in upper airway obstruction with or
without a cleft palate [2,3]; he later became the eponym
for this condition. In about 50% of affected children, RS is
not isolated but associated with other, mostly syndromic
anomalies [4-6]. Incidence figures are scant, ranging from
1:8500 for the Liverpool area to 1:14,000 for Denmark
[7,8]; there are no such data for Germany. One reason for
the rareness of birth prevalence data for RS is probably* Correspondence: Christian-f.poets@med.uni-tuebingen.de
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stated.that no consensus on diagnostic criteria exists for this
disorder.
RS can lead to complications such as failure to thrive,
hypoxemia or cor pulmonale. Although less distinctive
forms may only become apparent some weeks after birth
with snoring or obstructive sleep apnea (OSA), mandibu-
lar hypoplasia appears to be the main problem in RS, par-
ticularly if it is associated with the tongue being shifted
backwards (glossoptosis), so that its base compresses the
epiglottis. Glossoptosis may result in a narrow pharynx
and life-threatening respiratory distress [4,9].
At present there is no consensus about either diagnosis
or treatment, and procedures applied seem heterogeneous,
but epidemiologic data about their use are missing. We per-
formed a prospective epidemiologic study in Germany to
determine 1) the birth prevalence of RS, 2) the distributionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Patient characteristics
Total number 82
Initial presentation
Retrognathia 82 (100%; N = 82)
Breathing difficulties 63 (89%; N = 71)
Glossoptosis 47 (76%; N = 62)
Feeding/swallowing difficulties 68 (92%; N = 74)
Weight < 3rd percentile at admission 20 (35%; N = 57)
Cleft palate 58 (85%; N = 68)
RS-associated syndrome 28 (44%; N = 63)
Female 44 (54%; N = 82)
Age at admission (mean in days) 12 (min 0; max 301)
Gestational age (mean in weeks) 38 (min 30; max 41)
Age at discharge (mean in days) 48 (min 2; max 306)
Weight at birth (mean in grams) 2966 (min 890; max 4360)
Weight at admission (mean in grams) 3149 (min 890; max 7065)
SDS for weight −0.72
Weight at discharge (mean in grams) 3690 (min 2340; max 7330)
SDS for weight −1.46; p < 0.05
N refers to the number of questionnaires with data provided.
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on airway patency and growth.
Methods and patients
As part of the Surveillance Unit for Rare Pediatric Condi-
tions in Germany (ESPED), all pediatric departments (459
contact persons) received monthly reporting cards asking
them about new admissions of infants with RS between
August 2011 and July 2012. Reports on the mailing card
prompted immediate mailing of an anonymized three-
page questionnaire. Electronic reminders were sent to all
non-responders of the full questionnaire. In cases of per-
sistent missing return of the completed full questionnaire,
additional telephone requests were performed contacting
the local person responsible for the ESPED collaboration
(for details see [10]). Captured were all infants receiving
inpatient health care in a pediatric unit during their first
year of life independent of the indication leading to
hospitalization. Infants with mild expressions of RS never
admitted to a pediatric unit during this period were not
included. Inclusion criteria were retro-/micrognathia in
patients between 0–12 month of age as suspected by the
attending physician showing at least one of the following
additional criteria: upper airway obstruction, including
sub-/intercostal retractions, snoring or hypoxemia, glos-
soptosis, feeding difficulties, weight < 3rd percentile at ad-
mission, cleft palate or RS-associated syndrome. Regular
analyses of ESPED’s return rate for completed question-
naires consistently exceeds 93% [10,11].
Hospitals reporting a case received an anonymized three-
page questionnaire from the ESPED study center, designed
by our group and asking for basic demographic data and
clinical symptoms related to RS, occurrence of craniofacial
disorders in the family, time of diagnosis, diagnostic
procedures and treatment received, complications, nutri-
tion and growth (online supplement). An anonymized
medical report was also asked for. Having collected these
data, we excluded cases that were reported in duplicate or
did not meet inclusion criteria. To determine the birth
prevalence of RS, we used data from the National Bureau
of Statistics on the number of births in Germany [12].
As this is an explorative study without a primary
hypothesis, no sample size calculations were done. De-
scriptive statistics were applied to characterize the study
population. For evaluating weight gain, standard devi-
ation score (SDS) for weight was computed using the
Microsoft Excel add-in LMS Growth (version 2.14; www.
healthforallchildren.com/?product=lmsgrowth) and com-
pared using non-parametric tests. The reference popula-
tion for this program is the British 1990 growth reference
fitted by maximum penalized likelihood [13,14].
A p-value <0.05 was considered statistically significant.
Analyses were done with statistical software (SPSS,
release 21.0 for Mac; Chicago, Illinois, USA).The study protocol, including a parental consent waiver,
was approved by the ethics committee of Tuebingen
University Hospital.
Results
Between August 2011 and July 2012, a total of 96 patients
with RS were reported to the study center; detailed
information was supplied via returned questionnaires in
91, yielding a response rate of 95%. Of these 91 cases, 82
could be verified, two were erroneous notifications, having
a diagnosis other than RS, and 7 were duplicate cases.
Given 662,712 live births in Germany in 2011 a birth
prevalence of 12.4 per 100,000 live births results. Patient
characteristics are shown in Table 1. Unfortunately, sev-
eral respondents did not provide answers to all items of
the questionnaire. Response rates for single items there-
fore ranged from 70 to 100%.
Of the 82 infants with RS, information about associ-
ated syndromes was provided in 56: 28 were isolated RS
and 28 had additional syndromic features (Table 2). An
underlying genetic disorder was diagnosed either by the
attending pediatrician or a geneticist, but only 50% of
infants with RS were referred to a geneticist.
In 13 children, the malformation was observed pre-
natally, in 7 pregnancies a polyhydramnion had been
noted and a family history of a craniofacial condition
was found in 8 patients. A diagnosis of RS was made on
the day of birth in 58 infants, in 9 during the first week
of life, in five in the first month and in one case after the
first month of age.














Trisomy 13 (Pätau syndrome) 1
VACTERL association 1
Table 4 Implemented therapies
Infants with available information on implemented therapies 76*
Prone positioning 50




Preepiglottic baton plate 19
Tracheotomy 3




Functional therapy (orofacial regulation therapy,
e.g. Castillo Morales)
47
*For 61/76 infants, more than 1 intervention was reported.
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supplied) experienced respiratory difficulties necessitating
respiratory support.
In the first week after birth, 40 patients received
nasogastric tube feeding, 16 were fed via a Habermann
feeder and in 10 conventional bottle feeding was used.
Other performed procedures are shown in Table 3 and
implemented therapeutic interventions in Table 4.
Nutritional supply at discharge occurred in 26 children
via nasogastric tube, in 21 via feeding with a regular
nipple and in 12 with the Habermann feeder. Fifty-six
children were able to feed independently at discharge.
Considering SDS for weight, there was a decrease
from −0,72 at admission to −1,46 at discharge (p < 0.05).
Discussion
This is the first epidemiological study on Robin sequence
from Germany. The 82 cases of infants with RS reported
here correspond to a birth prevalence of about 1:8080,
which is in the upper range of that reported by others
[7,8,15]. Nevertheless our data still might represent anTable 3 Investigations performed; N refers to the number
of questionnaires with data provided
Polysomnography (sleep study) 22 (34%; N = 64)
Obstructive apneas identified 22 (100%; N = 22)
Endoscopy 27 (40%; N = 67)
Orthodontic investigation 43 (59%; N = 73)
Oral and maxillofacial investigation 55 (78%; N = 71)
ENT investigation 26 (40%; N = 65)
Genetic consultation 36 (50%; N = 72)
Neuropediatric investigation 42 (62%; N = 68)underestimation of birth prevalence as potentially some
mild cases of infants with RS were missed if they had
never been hospitalized in pediatric units. Another
study found a birth prevalence of 1:2500 for infants
with nonsyndromic cleft palates, about one quarter of
these representing infants with RS [16]. Further incidence
data on the disorder are sparse as many other studies
consist of (large) case series [17-19].
Prenatal detection of RS was rare. In 71% of recorded
infants a suspicion of RS was raised on the day of birth
suggesting that in a substantial proportion of infants
initial diagnosis and implementation of adequate diag-
nostic evaluation could have been missed or at least
delayed. This might result in a significantly enhanced
risk of affected babies from severe, underestimated
breathing difficulties due to unrecognized UAO in their
first days of life. Hence improvement of the prenatal
detection rate of RS and prenatal referral to a reference
center is a substantial concern, at least in Germany.
Additionally, higher awareness in midwives and obstetri-
cians of characteristic symptoms and potential conse-
quences of UAO related to the disorder could contribute
to earlier recognition of leading symptoms of RS and
might allow for a more timely surveillance and treat-
ment of affected neonates. This could potentially lead to
an alleviation of long-term consequences resulting from
unrecognized hypoxia.
When designing a survey such as this, applying a cor-
rect definition is paramount. In RS, this is hampered by
the fact that there is considerable variability regarding
its definition. To minimize potential underreporting, we
used a rather broad definition (retrognathia) plus one of
the other symptoms/components listed in a recent
survey on diagnostic criteria for RS [20,21]. Reassuringly,
however, 89% of infants were reported do have respiratory
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RS. Glossoptosis, however, was reported in only 71%. In
our experience as a referral center for RS, glossoptosis
may not always be detected by pediatricians not familiar
with it.
The distribution of syndromic vs. non-syndromic RS is
in line with other studies, although some syndromic
forms of RS may have been missed as only 50% were
referred to a geneticist [4,5]. Particularly Stickler syn-
drome may have been missed, as its clinical features are
often not immediately apparent after birth [22].
When comparing the diagnostic procedures applied,
we realized that only 34% of respondents had used
polysomnography, the gold standard for detecting OSA
in children with RS [23-25]. This may have led to an
underrecognition of sleep-related upper airway obstruc-
tion, thus misinforming subsequent therapy.
Regarding treatment, we noted that surgical interven-
tions, frequently reported by others [26,27], are apparently
only rarely performed in Germany. Only 3 children
received tracheostomy and 2 were treated with mandibu-
lar traction. Treatments most commonly applied were
prone positioning in 50/82 infants, followed by functional
therapy through a speech therapist (e.g. Castillo Morales);
for details see Table 4. Castillo-Morales therapy, originally
developed for children with Down syndrome, involves
stimulation of the orofacial musculature to help relieving
upper airway obstruction (UAO) [28], but has never been
systematically studied in RS. Prone positioning has been
described in some case series as a sufficient treatment
modality in 50 to 80% of RS infants [19,29], but its
effectiveness has also not been proven objectively (e.g., by
polysomnography). Furthermore, it is concerning that
studies report a more than 10-fold increase in the risk of
sudden infant death syndrome in healthy infants placed
prone for sleep, making it questionable whether parents
can safely be advised to place their baby with RS prone
for sleep [25].
In our survey, the use of palatal plates was reported in
53 infants. These have been shown to resolve glossopto-
sis and airway obstruction [30], however, feeding prob-
lems may persist. Use of the preepiglottic baton plate
(PEBP) was reported in 19 infants (by 10 centers); it is
yet the only intervention for RS whose effectiveness has
been tested in a randomized controlled trial [31].
At the time of admission, 40 infants were tube fed, this
number was reduced to 26 by the time of hospital
discharge; SDS for weight allows assessing weight gain
objectively. When comparing SDS for weight at admis-
sion and discharge, we saw a decrease by 0.7 standard
deviations. Thus, although many infants were discharged
without nasogastric tube feeding, they apparently did
not gain weight appropriately. Unfortunately, underlying
reasons remain unclear. Considering the fact that UAOin the majority of infants was treated with prone posi-
tioning as the sole intervention one may speculate that
high energy expenditure due to insufficiently treated
breathing difficulties based on UAO could be an import-
ant source of faltering growth. Poor feeding resulting
from swallowing and breathing difficulties might be
another reason. In order to elucidate the influence of
different factors leading to faltering growth, such as
enhanced energy expenditure due to undertreated UAO,
feeding difficulties or a potentially underlying genetic
disorder, growth data during infancy under different
treatment modalities should be evaluated. This could
lead to a better appreciation of growth problems in in-
fants with RS and in the long term to a reduction of
poor growth and its long-term consequences in this
population.
We received information on cases only some weeks or
months after admission. Our data may thus be subject to
recall bias. As questionnaires were not always completed
throughout, there is lacking information for several items,
the latter also potentially biasing our results. Also, we have
no way to ascertain how many cases were missed. Notably
outpatients never having required pediatric inpatient
treatment or having died prior to transport to a monitor-
ing unit (i.e., a pediatric department) might not have been
captured. Thus, patients with mild characteristics of RS
might have been missed. This is a limitation of our study.
Unfortunately, there are no guidelines in Germany as to
whether an infant with suspected RS has to be admitted
to a hospital as an inpatient for further evaluation and
initial treatment. On the other hand, it is reassuring that
our birth prevalence data are in the upper range of what
has been reported by others [7,8], and response rates with
the ESPED surveillance system are high [10]. Finally, our
definition for RS differed from that used by others [21,32],
leading to uncertainty in comparing our results with
published data on birth prevalence rates for RS.Conclusion
The birth prevalence of RS in Germany is about 1:8000
life births and surgical therapeutic options, dominating
the international literature, do not seem to play a major
role. Nonetheless, our data confirm that achieving nor-
mal weight gain remains a challenge, and we have no
data to ascertain whether UAO, frequently encountered
in these infants, was resolved by the therapies applied.
Abbreviations
(RS): Robin sequence; (PEBP): Preepiglotic baton plate; (OSA): Obstructive
sleep apnea; (ESPED): Surveillance unit for rare pediatric conditions in
Germany; (SDS): Standard devation score; (UAO): Upper airway obstruction.
Competing interests
The authors have indicated they have no financial relationships relevant to
this article or any conflict of interest to disclose.
Vatlach et al. Orphanet Journal of Rare Diseases 2014, 9:9 Page 5 of 5
http://www.ojrd.com/content/9/1/9Authors’ contributions
Dr. SV coordinated the data collection, analyzed the data and wrote the first
draft of this manuscript, Dr. CM revised the manuscript and helped with data
collection, and CFP initiated and supervised the study and revised the
manuscript. All authors read and approved the final manuscript.Acknowledgements
We would like to thank the German Surveillance Unit for Rare Pediatric
Diseases (Erhebungseinheit für seltene pädiatrische Erkankungen in
Deutschland (ESPED)) and especially Mrs. Beate Heinrich, and the German
Ministry of Research and Technology for funding this study. We also thank
all reporting colleagues for their help with this study.
Received: 19 October 2013 Accepted: 12 January 2014
Published: 17 January 2014References
1. Shukowsky W: Zur Ätiologie des Stridor inspiratorius congenitus.
Cleft Palate Craniofac J 1911, 29:205–209.
2. Robin P: La chute de la base de la langue consideree comme une
nouvelle cause de gene dans la respiration naso-pharygienne.
Bull Acad Med 1923, 89:37–41.
3. Robin P: Glossoptosis due to atresia and hypotrophy of the manible.
Am J Dis Child 1934, 48:541–547.
4. Linz A, Bacher M, Urschitz MS, Buchenau W, Arand J, Poets CF: Diagnostik
und Therapie der Pierre-Robin-Sequenz. Monatsschr Kinderheilkd 2011,
159:1228–1233.
5. Cohen MM Jr: Robin sequences and complexes: causal heterogeneity
and pathogenetic/phenotypic variability. Am J Med Genet 1999,
84:311–315.
6. Izumi K, Konczal LL, Mitchell AL, Jones MC: Underlying genetic
diagnosis of Pierre Robin sequence: retrospective chart review at two
children‘s hospitals and a systematic literature review. J Pediatr 2012,
160:645–650. e642.
7. Bush PG, Williams AJ: Incidence of the Robin Anomalad
(Pierre Robin syndrome). Br J Plast Surg 1983, 36:434–437.
8. Printzlau A, Andersen M: Pierre Robin sequence in Denmark: a
retrospective population-based epidemiological study. Cleft Palate
Craniofac J 2004, 41:47–52.
9. Sher AE: Mechanisms of airway obstruction in Robin sequence:
implications for treatment. Cleft Palate Craniofac J 1992, 29:224–231.
10. Gobel U, Heinrich B, Krauth KA, Steingruber HJ, von Kries R: Process and
outcome quality of the German Paediatric Surveillance Unit (ESPED).
Klin Padiatr 2010, 222:92–97.
11. ESPED-Jahresbericht; 2011. http://www.esped.uni-duesseldorf.de/.
12. Statistisches Bundesamt, Geborene und Gestorbene; 2011. http://www.bpb.de/
nachschlagen/zahlen-und-fakten/soziale-situation-in-deutschland/61559/
geborene-und-gestorbene, Accessed Jan 14, 2014.
13. Cole T, JV F, MA P: British, growth reference centiles for weight, height,
body mass index and head circumference fitted by maximum penalized
likelihood. Stat Med 1990, 1998:407–429.
14. Freeman J, TJ C, SF C, PR J, EM W, MA P: Cross sectional stature and
weight reference curves for the UK, 1990. Arch Dis Child 1995, 73:17–24.
15. Kallen B, Harris J, Robert E: The epidemiology of orofacial clefts. 2.
Associated malformations. J Craniofac Genet Dev Biol 1996, 16:242–248.
16. Genisca AE, Frias JL, Broussard CS, Honein MA, Lammer EJ, Moore CA, Shaw
GM, Murray JC, Yang W, Rasmussen SA, National Birth Defects Prevention S:
Orofacial clefts in the National Birth Defects Prevention Study,
1997–2004. Am J Med Genet A 2009, 149A:1149–1158.
17. Holder-Espinasse M, Abadie V, Cormier-Daire V, Beyler C, Manach Y,
Munnich A, Lyonnet S, Couly G, Amiel J: Pierre Robin sequence: a series
of 117 consecutive cases. J Pediatr 2001, 139:588–590.
18. Evans AK, Rahbar R, Rogers GF, Mulliken JB, Volk MS: Robin sequence: a
retrospective review of 115 patients. Int J Pediatr Otorhinolaryngol 2006,
70:973–980.
19. Caouette-Laberge L, Bayet B, Larocque Y: The Pierre Robin sequence:
review of 125 cases and evolution of treatment modalities. Plast Reconstr
Surg 1994, 93:934–942.
20. Breugem CC, Courtemanche DJ: Robin sequence: clearing nosologic
confusion. Cleft Palate Craniofac J 2010, 47:197–200.21. Breugem CC, Mink van der Molen AB: What is ‘Pierre Robin sequence’?
J Plast Reconstr Aesthet Surg 2009, 62:1555–1558.
22. Stickler GB, Hughes W, Houchin P: Clinical features of hereditary
progressive arthro-ophthalmopathy (Stickler syndrome): a survey.
Genet Med 2001, 3:192–196.
23. Anderson IC, Sedaghat AR, McGinley BM, Redett RJ, Boss EF, Ishman SL:
Prevalence and severity of obstructive sleep apnea and snoring in
infants with pierre robin sequence. Cleft Palate Craniofac J 2011,
48:614–618.
24. Gilhooly JT, Smith JD, Howell LL, Deschaine BL, Richey SL: Bedside
polysomnography as an adjunct in the management of infants with
Robin sequence. Plast Reconstr Surg 1993, 92:23–27.
25. Poets CF, Bacher M: Treatment of upper airway obstruction and feeding
problems in Robin-like phenotype. J Pediatr 2011, 159:887–892.
26. Denny AD, Talisman R, Hanson PR, Recinos RF: Mandibular distraction
osteogenesis in very young patients to correct airway obstruction.
Plast Reconstr Surg 2001, 108:302–311.
27. Scott AR, Tibesar RJ, Sidman JD: Pierre Robin Sequence: evaluation,
management, indications for surgery, and pitfalls. Otolaryngol Clin North
Am 2012, 45:695–710.
28. Limbrock GJ, Castillo-Morales R, Hoyer H, Stover B, Onufer CN: The
Castillo-Morales approach to orofacial pathology in Down syndrome.
Int J Orofacial Myology 1993, 19:30–37.
29. Kirschner RE, Low DW, Randall P, Bartlett SP, McDonald-McGinn DM,
Schultz PJ, Zackai EH, LaRossa D: Surgical airway management in Pierre
Robin sequence: is there a role for tongue-lip adhesion? Cleft Palate
Craniofac J 2003, 40:13–18.
30. Butow KW, Hoogendijk CF, Zwahlen RA: Pierre Robin sequence:
appearances and 25 years of experience with an innovative treatment
protocol. J Pediatr Surg 2009, 44:2112–2118.
31. Bacher M, Sautermeister J, Urschitz MS, Buchenau W, Arand J, Poets CF: An
oral appliance with velar extension for treatment of obstructive sleep
apnea in infants with pierre robin sequence. Cleft Palate Craniofac J 2011,
48:331–336.
32. Breugem C, Paes E, Kon M, van der Molen AB: Bioresorbable distraction
device for the treatment of airway problems for infants with Robin
sequence. Clin Oral Investig 2012, 16:1325–1331.
doi:10.1186/1750-1172-9-9
Cite this article as: Vatlach et al.: Birth prevalence and initial treatment
of Robin sequence in Germany: a prospective epidemiologic study.
Orphanet Journal of Rare Diseases 2014 9:9.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
